• Twitter
  • Facebook
  • LinkedIn
  • English English English en
  • Português Português Portuguese (Brazil) pt-br
Murray Advogados
  • Home
  • The Firm
  • Areas
    • More…
      • Probate and Family Law
      • Capital Stock
      • Internet & Electronic Trade
      • Life Sciences
      • Capital and Financial Market Banking Law
      • Media e Entertainment
      • Mining
      • Intellectual Property
      • Telecommunications Law and Policy
      • Visas
    • Arbitration
    • Adminstrative Law
    • Environmental Law
    • Civil Law
    • Trade Law
    • Consumer Law
    • Sports Law
    • Market and Antitrust Law
    • Real Estate Law
    • International Law and Foreign Trade
    • Corporate Law
    • Labor Law
    • Tax Law
    • Power, Oil and Gas
  • Members
  • News
  • Links
  • Contact
    • Contact Us
    • Careers
  • Search
  • Menu Menu
Murray News

Brazil seeks biotech approval deal with China

At least ten GM seed varieties remain unused due to delayed clearance from Beijing

 

 

 

 

05/05/2025

Croplife Brasil—the organization representing biotech companies—along with the national associations of corn (Abramilho) and cotton (Abrapa) producers and the Brazilian Agricultural Research Corporation (Embrapa) will seek to advance negotiations with Chinese authorities for a long-awaited agreement on the synchronized approval of genetically modified (GM) crops.

At least ten GM seed varieties already approved in Brazil have not been planted because they are still under review in China—a process that can take up to eight years. Since China is the primary buyer of Brazilian soybeans and a major importer of Brazilian corn, exporting products containing traits not approved in China could trigger trade barriers.

Eduardo Leão, executive director of Croplife Brasil, said the goal is to sign a memorandum of understanding that would align approval processes between the two countries and open the door for China to export its own biotechnology to Brazil. “We are optimistic, as the timing is favorable. China has been investing more in biotechnology and gene editing, and there’s growing interest in exporting this technology to Brazil,” he told Valor.

While the Brazilian delegation is in China, the biotechnology committee of the China-Brazil High-Level Commission for Consultation and Cooperation (Cosban) will meet to address the issue. Mr. Leão noted that President Lula’s presence in the country will help “boost” the sector’s outreach.

“The relationship with China has reached a level of maturity, transparency, and clarity among the negotiating teams that is unprecedented,” said Luis Rua, secretary of international relations at the Ministry of Agriculture. “This has enabled significant progress.”

The National Union of Corn Ethanol (Unem) will also host a seminar with Chinese importers to promote dried distillers grains (DDG), a high-protein byproduct of ethanol production used in animal feed. Market access for DDG is one of the key items on Agriculture Minister Carlos Fávaro’s agenda during talks with Chinese authorities.

“This is a very opportune moment for Brazil to position itself, as two global powers are hitting each other with tariffs,” said Guilherme Nolasco, president of Unem. “This opens opportunities, and we must be ready to play. Brazil is the reliable alternative for food and energy supply.” He noted that Brazil’s efforts to sell DDG and ethanol to China began before Donald Trump returned to the U.S. presidency.

Brazilian orange juice exporters, meanwhile, are pushing for a tariff adjustment that would provide greater predictability in trade relations with China and potentially encourage future Brazilian investments in the country.

Currently, there are two export tax rates for orange juice—7.5% and 20%—depending on the temperature at which the product arrives at Chinese ports. The industry is seeking to unify the tariff at 7.5%, even though this lower rate currently results in higher energy and logistics costs.

*By Rafael Walendorff, Globo Rural — Brasília

Source: Valor International

https://valorinternational.globo.com/

5 de May de 2025/by Gelcy Bueno
Tags: Brazil seeks biotech approval deal with China
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail

Pesquisa

Posts Recentes

  • GNA opens Brazil’s largest thermal power plant at Porto do Açu
  • Trump tariffs stall wood pulp price recovery
  • Share block sales hit R$15bn, nearing record in Brazil
  • NEWSLETTER MAY 2025 – MURRAY ADVOGADOS
  • Tariff war sends shipping rates soaring in Brazil

Arquivos

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
© Copyright 2023 Murray Advogados – PLG International Lawyers - Support Webgui Design
  • Twitter
  • Facebook
  • LinkedIn
Brazilian agribusiness missions head to China to expand market presence Trade war also creates opportunities for Brazil
Scroll to top